Sanofi Prices EUR 2.3 Bln Notes Offering Across Three Tranches

Sanofi priced 2.3 billion euros of notes across three tranches, indicating continued access to the debt capital markets. The company said it will use the net proceeds for general corporate purposes. The announcement is routine financing activity and is unlikely to have a meaningful immediate market impact.

Analysis

Sanofi priced 2.3 billion euros of notes across three tranches, indicating continued access to the debt capital markets. The company said it will use the net proceeds for general corporate purposes. The announcement is routine financing activity and is unlikely to have a meaningful immediate market impact.